| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.6 | 0.03 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.03 |